<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00602095</url>
  </required_header>
  <id_info>
    <org_study_id>LMS2007</org_study_id>
    <secondary_id>KS2007</secondary_id>
    <nct_id>NCT00602095</nct_id>
  </id_info>
  <brief_title>Labour Induction With Misoprostol, Dinoprostone and Bard Catheter</brief_title>
  <acronym>LI</acronym>
  <official_title>A Randomised Comparison Between Intravaginal Dinoprostone Intravaginal Misoprostol and Transcervical Balloon Catheter for Labour Induction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised study aimed at comparing the currently most frequently used
      prostaglandin dinoprostone to two other methods, the cheaper and perhaps more effective
      prostaglandin misoprostol and a transcervical catheter. 592 women were recruited and
      randomised to one of the three methods. The main outcome measures were time to delivery, rate
      of instrumental deliveries and maternal neonatal outcome. Our hypothesis was that misoprostol
      would be superior to the other methods.

      The main finding of our trial was that the catheter showed the shortest induction to delivery
      interval. There were no differences between the two other prostaglandins. No differences in
      maternal and neonatal outcome was found
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from treatment start to delivery</measure>
    <time_frame>At delivery</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">592</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Labour induction with misoprostol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Labour induction with dinoprostone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Labour induction with bard</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>misoprostol</intervention_name>
    <description>0.025mg tablet vaginally every 4 hour until progress</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Cytotec, one quarter of a 0.100mg tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dinoprostone</intervention_name>
    <description>2mg vaginal gel every 6 hours until progress</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Minprostin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bard Catheter (balloon catheter)</intervention_name>
    <description>Intracervical balloon catheter positioned above internal cervical os and filled with sterile water. Removed when cervix was dilated</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Bard Catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Full term singleton pregnancy with vertex presentation and with an indication for
             labour induction.

          -  Absence of active labour

          -  Bishop score â‰¤ 6.

          -  Normal CTG registration

        Exclusion Criteria:

          -  Previous cesarean section

          -  signs of infection

          -  immediate need for delivery

          -  any contraindication for vaginal delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lena Marions, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital Institute</affiliation>
  </overall_official>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2008</study_first_submitted>
  <study_first_submitted_qc>January 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2008</study_first_posted>
  <last_update_submitted>January 15, 2008</last_update_submitted>
  <last_update_submitted_qc>January 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Lena Marions MD PhD</name_title>
    <organization>Karolinska University Hospital</organization>
  </responsible_party>
  <keyword>Labor induction</keyword>
  <keyword>cervical ripening</keyword>
  <keyword>misoprostol</keyword>
  <keyword>dinoprostone</keyword>
  <keyword>balloon catheter</keyword>
  <keyword>prostaglandin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

